Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center

Bone Marrow Transplant. 2018 Apr;53(4):503-506. doi: 10.1038/s41409-017-0068-2. Epub 2018 Jan 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / pharmacology
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aged
  • Brazil
  • Chronic Disease
  • Female
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Nitriles
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Pyrimidines
  • Remission Induction / methods
  • Salvage Therapy / adverse effects
  • Salvage Therapy / methods*
  • Treatment Outcome
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib